Alpelisib Active Not Recruiting Phase 1 Trials for Advanced Solid Tumors With an Alteration of the PIK3CA Gene / Estrogen Receptor Positive Breast Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01219699A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene